Related Experiment Video
Updated: May 6, 2026

07:50
Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis
Published on: December 8, 2023
1.3K
Two new schisdilactone-type compounds from Schisandra chinensis
Lin-Fu Li1, Hai-Qing Liu, Rui Zhang
1a Pharmaceutical College, Gannan Medical University , Ganzhou , 341000 , China.
Journal of Asian Natural Products Research
|October 24, 2013
Summary
Two novel schisdilactone compounds were identified from Schisandra chinensis stems. Their structures and configurations were determined using advanced spectroscopic and computational methods.
Area of Science:
- Natural Product Chemistry
- Organic Chemistry
- Phytochemistry
Background:
- Schisandra chinensis is a medicinal plant with a rich history in traditional medicine.
- The isolation of novel compounds from natural sources is crucial for drug discovery.
- Schisodilactones are a class of compounds with potential biological activities.
Purpose of the Study:
- To isolate and characterize new schisodilactone-type compounds from Schisandra chinensis.
- To elucidate the structures and absolute configurations of the newly discovered compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through extensive spectroscopic analysis (NMR, MS, etc.).
- Determination of absolute configurations using time-dependent density functional theory (TD-DFT) electronic circular dichroism (ECD) calculations.
Main Results:
- Two new schisdilactone-type compounds, schisodilactone H (1) and schisodilactone I (2), were successfully isolated.
- The detailed structures and absolute configurations of compounds 1 and 2 were unambiguously determined.
Conclusions:
- The study expands the known chemical diversity of schisodilactones.
- The findings contribute to the understanding of Schisandra chinensis phytochemistry.
- The characterized compounds serve as potential leads for further pharmacological investigations.
Related Concept Videos
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
3.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.2K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.3K
